Starvation is not the goal here
Targeting GLP-1 Receptors As we mentioned above, Semaglutide belongs to the class of glucagon-like peptide-1 (GLP-1) receptor agonists
Explore detailed drug insights and clinical data at www.clival.com #GLP1 #DiabetesCare #ObesityTreatment #PharmaInsights #DrugDatabase #ClivalDatabase To view or add a comment, sign in Indias drug regulator has officially approved Ozempic (semaglutide injection) by Novo Nordisk for the treatment of Type 2 Diabetes
This happens for several reasons that are all completely normal
Drug companies are cashing in while they can Novo Nordisk, the Danish creator of Ozempic and Wegovy, made $4.8 billion from the drugs in the third quarter of 2023 alone, boosting the economy in Denmark and leading to lower interest rates for ordinary Danes
For example, instead of eating a whole chicken breast, a cup of rice, and a cup of broccoli for dinner, split that into two separate meals eaten three hours apart